BioSpace News Archive

The global platelet rich plasma market is expected to drive growth at a CAGR of 11.6% during the forecast period and to reach valuation around US$ 708.64 million by 2030.

According to Precedence Research, the remote patient monitoring systems market is expected to reach US$ 5,101 million by 2030 and expanding growth at a CAGR of 20% over the forecast period 2022 to 2030.

The systemic inflammatory response syndrome treatment market is expected to reach at a CAGR of 7.37% over the forecast period and to hit valuation around US$ 21.36 billion by 2030.

Akron BioProducts, a leading manufacturer of cGMP-compliant technologies for cell and gene therapy, and Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced an agreement to develop and manufacture cGMP nucleases.

The targeted therapeutics market size was reached at US$ 67 billion in 2021 and is predicted to hit US$ 109 billion by 2028 with a registered CAGR of 2.4% from 2021 to 2030.

Precedence Research predicts, the ventilator market size was valued at US$ 2.7 billion in 2021 and is predicted to hit US$ 5.3 billion by 2028 and growing at a CAGR of 10% over the forecast period 2021 to 2030.

Several leading genomics companies and laboratories, including Illumina, Fulgent Genetics, Invitae, GeneDx, and PerkinElmer Genomics, have formed the CardioGenomic Testing Alliance (CGTA), a collaborative group aimed at raising awareness and utilization of genomic testing in cardiology.

Paige, the global leader in AI-based diagnostic software in pathology, today launched its latest product, Paige Breast Lymph Node, an AI medical device software that helps pathologists detect if breast cancer has metastasized to lymph nodes, concurrent with pathologists’ own interpretive review*.

Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, today announced that management plans to present and host investor meetings at two upcoming healthcare conferences.

ImmersiveTouch, the leading medical technology company with proprietary image-guided virtual and augmented reality (VR/AR) surgical planning & navigation platforms, today announced a strategic collaboration with Mayo Clinic.